NOV03 (Perfluorohexylcotane)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NOV03 (Perfluorohexylcotane), covering 2024-10-23 to 2024-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study) [Phase 3]